Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Prescribing costs in primary care PDF full book. Access full book title Prescribing costs in primary care by Great Britain: National Audit Office. Download full books in PDF and EPUB format.
Author: Great Britain: National Audit Office Publisher: The Stationery Office ISBN: 9780102945171 Category : Medical Languages : en Pages : 44
Book Description
The National Health Service spends £8 billion a year on prescription drugs in primary care in England. This has grown 60% in real terms over the last decade and the trend continues to be upward. This report examines how the money could be spent more efficiently, without compromising clinical outcomes. It looks principally at the scope for more cost-effective prescribing; supporting the GPs and PCTs in getting better value for money; and the wastage of drugs. For four groups of drugs (which account for 19% of the total drugs bill), it finds a wide disparity in prescribing behaviour. It estimates that if all PCTs attained the standard of the best 25%, £200 million could be saved. The analysis shows that there are several mechanism to improve value for money. They include: personalised communication with GPs from local experts, financial and practical incentives, and involving the whole primary and local care community in decisions about drug policy. Wastage of drugs is a problem but the level is not monitored and the uptake of initiatives to reduce the amount of waste is low. Assessing whether local prescribing volumes are consistent with clinical need is complex, but combining prescription data with local prevalence data can provide benchmark information.
Author: Great Britain: National Audit Office Publisher: The Stationery Office ISBN: 9780102945171 Category : Medical Languages : en Pages : 44
Book Description
The National Health Service spends £8 billion a year on prescription drugs in primary care in England. This has grown 60% in real terms over the last decade and the trend continues to be upward. This report examines how the money could be spent more efficiently, without compromising clinical outcomes. It looks principally at the scope for more cost-effective prescribing; supporting the GPs and PCTs in getting better value for money; and the wastage of drugs. For four groups of drugs (which account for 19% of the total drugs bill), it finds a wide disparity in prescribing behaviour. It estimates that if all PCTs attained the standard of the best 25%, £200 million could be saved. The analysis shows that there are several mechanism to improve value for money. They include: personalised communication with GPs from local experts, financial and practical incentives, and involving the whole primary and local care community in decisions about drug policy. Wastage of drugs is a problem but the level is not monitored and the uptake of initiatives to reduce the amount of waste is low. Assessing whether local prescribing volumes are consistent with clinical need is complex, but combining prescription data with local prevalence data can provide benchmark information.
Author: National Academies of Sciences, Engineering, and Medicine Publisher: National Academies Press ISBN: 0309468086 Category : Medical Languages : en Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Great Britain: Parliament: House of Commons: Committee of Public Accounts Publisher: The Stationery Office ISBN: 9780215037992 Category : Medical Languages : en Pages : 40
Book Description
This report, from the Committee of Public Accounts, examines the cost of prescriptions in primary care. It is estimated that around a quarter of all expenditure in primary care is on drugs. In 1996, the number of prescriptions was 485 million, dispensed in England; by 2006 this had increased by 55% to 752 million, with the primary care drugs bill increasing from £4.0 billion to £8.2 billion, a 60% increase. The Committee took evidence from the Department of Health, on the basis of an earlier report from the NAO (HCP 173, session 2006-07, ISBN 9780102945171). The Committee has set out a number of conclusions and recommendations, including: that the NHS could save more than £200 million a year by GPs prescribing lower cost drugs, particularly those described as generic versions of the drug, as opposed to brand name drugs; that the proportion of lower cost prescriptions for some common conditions varies greatly between Primary Care Trusts (PCTs), and that the Strategic Health Authorities should work with the National Prescribing Centre to develop best practice in prescriptions; that an index comparing GP practices and PCTs on efficient prescribing might promote a culture of best practice; that the influence of pharmaceutical companies on prescribing decisions should be monitored by the Department of Health, with a minimal level set for gifts and hospitality offered by such companies to GPs and PCTs; there should be better information on unused and wasted drugs in the NHS, with an estimated cost of £100 million a year; that the Department of Health should explore with the pharmaceutical industry to achieve greater consistency in labelling and packaging of generic versions of the more common drugs supplied to the NHS
Author: Vineet Arora Publisher: McGraw Hill Professional ISBN: 007181700X Category : Medical Languages : en Pages : 417
Book Description
Provide outstanding healthcare while keeping within budget with this comprehensive, engagingly written guide Understanding Value-Based Healthcare is a succinct, interestingly written primer on the core issues involved in maximizing the efficacy and outcomes of medical care when cost is a factor in the decision-making process. Written by internationally recognized experts on cost- and value-based healthcare, this timely book delivers practical and clinically focused guidance on one of the most debated topics in medicine and medicine administration today. Understanding Value-Based Healthcare is divided into three sections: Section 1 Introduction to Value in Healthcare lays the groundwork for understanding this complex topic. Coverage includes the current state of healthcare costs and waste in the USA, the challenges of understanding healthcare pricing, ethics of cost-conscious care, and more. Section 2 Causes of Waste covers important issues such as variation in resource utilization, the role of technology diffusion, lost opportunities to deliver value, and barriers to providing high-value care. Section 3 Solutions and Tools discusses teaching cost awareness and evidence-based medicine, the role of patients, high-value medication prescribing, screening and prevention, incentives, and implementing value-based initiatives. The authors include valuable case studies within each chapter to demonstrate how the material relates to real-world situations faced by clinicians on a daily basis. .
Author: Peter J. Neumann Publisher: Oxford University Press ISBN: 0197512887 Category : Business & Economics Languages : en Pages : 273
Book Description
The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it anyway? -- Institute for Clinical and Economic Review (ICER) -- Other US value assessment frameworks -- Do drugs for special populations warrant higher prices? -- Improving value measurement -- Aligning prices with value -- The path forward.
Author: Conrad M Harris Publisher: CRC Press ISBN: 1315342766 Category : Medical Languages : en Pages : 195
Book Description
Management controls on prescribing have greater impact on a GP's freedom of choice than on any other matter requiring clinical judgement. However, in order to deliver the most effective patient care, the GP needs a much broader base of knowledge including, for example, an understanding of basic pharmacological principles and the process of conducting clinical trials. This book deals systematically with the practical aspects of prescribing throughout primary care. It provides the busy GP with readily-accessible information so that the benefit to patients and the pratice can be maximized.
Author: Great Britain: National Audit Office
Author: Great Britain: National Audit Office
Author: National Academies of Sciences, Engineering, and Medicine
Author: Great Britain: Parliament: House of Commons: Committee of Public Accounts
Author: 
Author: Royal College of Physicians of London
Author: 
Author: Vincenzo Atella
Author: Vineet Arora
Author: Peter J. Neumann
Author: Conrad M Harris